Europe
74% increase in revenues to € 9.3 million for the first nine months of 2018 versus same period in 2017
2018 scale-up of Biom’up’s manufacturing facility near Lyon (France) completed, allowing for a larger throughput and increased shipments of devices to the US and EU markets
The quality of medical certificates written by students of medicine was better when they were taught by using the flipped classroom approach instead of traditional lecturing.
Net sales amounted to SEK 1,421 million (1,200), an increase of 18%
TxCell SA today reports its financial information for the 3rd quarter of 2018.
GE Healthcare partners with Wego to provide locally manufactured single-use consumables for bioprocessing in China
Evotec AG announced today that its management will be presenting and attending the following upcoming conferences:
Companies bolstered their leadership with additions to boards of directors and c-suite offices.
The UK’s exit from the European Union, Brexit, will impact numerous industries in the UK and Europe, but the biopharma industry has its own unique challenges.
In announcing the round, Camel-IDS said the finances will be used for a phase Ib/II trial of its lead program CAM-H2, a treatment option in HER2-positive cancers, while further developing preclinical programs and broadening the pipeline.
PRESS RELEASES